Cardinal Health, Inc. Plans $90 Million in China Acquisitions

February 3, 2012 -- Cardinal Health, the US-based drug distributor, plans to make $90 million in China acquisitions to bolster its geographic coverage in mainland China. In addition, Cardinal said it is expanding its China product offerings to include medical products, lab equipment and other supplies. Cardinal bought a distribution foothold the PRC market in late 2010 by paying $470 million for Zuellig Pharma China, a company that specialized in distributing imported drugs in China. More details....

Stock Symbol: (NYSE: CAH)